Post-earnings recap
Reported
Fri, Jan 8, 2021
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
0%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
CytoDyn Inc. reported a loss per share of $0.06, which was below expectations. The stock reacted negatively, declining by 1.93%. The lack of revenue figures and guidance may contribute to investor uncertainty moving forward.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.06 | N/A | -20.00% |
| Revenue | — | N/A | — |
No transcript is on record for this earnings call, and the analysis is based solely on the numerical results presented.